0001415889-21-003266.txt : 20210629
0001415889-21-003266.hdr.sgml : 20210629
20210629191311
ACCESSION NUMBER: 0001415889-21-003266
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210625
FILED AS OF DATE: 20210629
DATE AS OF CHANGE: 20210629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheena Jonathan
CENTRAL INDEX KEY: 0001646649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211059698
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-06292021_040654.xml
X0306
4
2021-06-25
0001604821
Natera, Inc.
NTRA
0001646649
Sheena Jonathan
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
true
CO-FOUNDER
Common Stock
2021-06-25
4
M
0
87
5.3953
A
455472
D
Common Stock
2021-06-25
4
S
0
87
121.6314
D
455385
D
Common Stock
2021-06-25
4
M
0
52
9.59
A
455437
D
Common Stock
2021-06-25
4
S
0
52
121.6285
D
455385
D
Common Stock
2021-06-25
4
M
0
700
10.41
A
456085
D
Common Stock
2021-06-25
4
S
0
700
121.5829
D
455385
D
Common Stock
2021-06-25
4
M
0
700
9.29
A
456085
D
Common Stock
2021-06-25
4
S
0
700
121.5871
D
455385
D
Common Stock
2021-06-27
4
M
0
446
A
455831
D
Common Stock
2021-06-28
4
S
0
201
117.5714
D
455630
D
Stock Option (right to buy)
5.3953
2021-06-25
4
M
0
87
0
D
2026-04-07
Common Stock
87
1958
D
Stock Option (right to buy)
9.59
2021-06-25
4
M
0
52
0
D
2026-04-07
Common Stock
52
40778
D
Stock Option (right to buy)
10.41
2021-06-25
4
M
0
700
0
D
2027-06-08
Common Stock
700
38368
D
Stock Option (right to buy)
9.29
2021-06-25
4
M
0
700
0
D
2028-03-08
Common Stock
700
21453
D
Restricted Stock Unit
2021-06-27
4
M
0
446
0
D
Common Stock
446
4917
D
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.02 to $121.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.04 to $121.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.10 to $121.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.11 to $121.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 27, 2021.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
The option shares vested fully and became exercisable on November 20, 2019.
The option shares vested fully and became exercisable on April 1, 2020.
The option shares vested fully and became exercisable on March 21, 2021.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The RSUs vest over four years. 25% of the RSUs vested on March 27, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2021-06-29